News August 16, 2023 PHM Launches ClearCancerIQ™, a Proprietary Predictive Tool for Employers Seeking to Improve CancerCare and Reduce Spend PHM introduces ClearCancerIQ (CCIQ), the first-of-its-kind predictive analytics tool designed to help employers size their company’s cancer risk through quantitative analysis of their health plan population. An innovation in PHM’s ClearCancer™ suite of solutions, CCIQ enables companies to develop high impact strategies to manage cancer at both the employee and workforce level. Read More
News July 11, 2023 Innovative treatment for prostate cancer shows long term success PHM believes in the importance of having access to cutting-edge cancer diagnostics and therapeutics, and we are excited to announce our peer-reviewed case report in Frontiers in Oncology demonstrating why. This report summarizes the case of a 73 year-old male who went from stage 4B prostate cancer to disease free. Our client first came to PHM after a year of his diagnosis and there were early signs that standard treatments were not going to adequately control his disease. We connected him to a clinic in Germany using theranostics, a treatment for prostate cancer that was not yet approved in the U.S. He remains disease free five years later. Read More
Ask Our Experts July 10, 2023 Highlighting the latest in cancer research Each June, over 40,000 oncology professionals, including physicians, researchers, patient advocates, and pharmaceutical representatives attend the American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. This meeting is considered the premiere forum for the presentation of the most recent scientific progress made in the fight against cancer. This year, our Chief Scientist and Senior Vice President of Research, Eva Gordon, PhD and members of our Personal Care Teams of research scientists and advanced practice clinicians attended dozens of presentations to learn the latest clinical data and emerging technologies. They also connected with oncologists, patient advocates, and technology leaders in the cancer community. Here’s some of the most exciting developments at ASCO 2023. Read More
Case Studies July 10, 2023 Reclaiming quality of life Larry faced debilitating back pain and struggled to live a normal life. He saw as many as five different medical experts to get relief before reaching out to PHM. Through PHM's personalized care, Larry received not only a diagnosis, treatment, and plan of action that were fast-tracked and proved successful, but also a trusted guide who helped him navigate his healthcare journey and restore his overall well-being. Read More
Ask Our Experts July 10, 2023 Summer skin protection checklist While our skin needs protection from the sun throughout the year, the increased time spent in the sun during the summer can raise the risk of skin damage and skin cancer. Here is PHM’s recommended checklist on the best ways to protect yourself from the sun’s damaging UV rays and reduce your risk of developing skin cancer. Read More
Ask Our Experts July 10, 2023 Treating hot flashes without hormones Hot flashes are the most common symptom of menopause, occurring in 75% of all women and often persisting for years. For some women, hot flashes are mild, infrequent, and do not require treatment. Others have more intense and frequent hot flashes that negatively affect their quality of life, including sleep interruption, mood changes, difficulty concentrating, and interference with daily activities. Read now for a brief review the existing treatments and a newly approved, non-hormonal treatment option. Read More
